Search page

A Clinical Decision Support System (CDSS) based on Machine Learning for the diagnosis of Seasonal Allergenic Rhinitis (SAR) and patient-tailored AIT prescription

A Novel Mutation of MYOF in Hereditary Angioedema: the First Two Case Reports in Asia and Analysis of Clinical Characteristics

A Pendemic? A review of the prescription of adrenaline auto-injectors among new referrals to paediatric allergy clinics according to the updated European Academy of Allergy and Clinical Immunology guidelines (2021)

A Point-of-Care Diagnosis of Wheat-Dependent Exercise-Induced Anaphylaxis: The Clinical Utility of Novel Gliadins Skin Test

A Rare Case of Thyme Allergy in a Pediatric Patient: First Report and Clinical Insights

A case report of Oxacillin induced Steven-Johnson-Syndrome: a clinical experience

A clinical case of Erythema multiforme in pediatric patient

A clinical case of nodular prurigo in pediatric patient

A comparison of conventional vs cluster updosing venom immunotherapy in children in a tertiary hospital

A delivery platform for food allergy immunotherapy based on dissolvable microneedle array patches with ovalbumin mesoporous silica nanoparticles

A dose ranging study of sting challenge and specific lgE, IgG4, venom skin test and basophil activation responses to ant venom immunotherapy with and without delta-inulin adjuvant

A step towards standardized Clinical Remission Criteria for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): insights from a real-life study

AI as a game-changer: predicting biomarkers to transform allergy immunotherapy

ALK – Expanding AIT evidence with new phase III clinical data in children with respiratory allergy

Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants

Absence of alpha-tryptase isoforms is associated with less severe adverse events during peanut-oral immunotherapy

Achieving Remission with Peanut Sublingual Immunotherapy

Action plan in different FPIES clinical cases

Active immunotherapy with recombinant Bet v 1

Adherence to venom immunotherapy : a french monocentric retrospective study

Adrenaline devices : potential consequences for clinical practice

Adult Diet: The immunesupportive diet in clinical practice

Advances in Allergen Immunotherapy

Advances in Allergen Immunotherapy (AIT)

Advances in Immunotherapy

Advances in Oral Immunotherapy

Advances in epicutaneous immunotherapy for the management of patients with food allergy

Advancing AIT in the clinical management of children with respiratory allergy

Advancing Drug Allergy Diagnosis: The Role of In Vitro Tests and Biomarkers in Clinical Practice

Allergen Immunotherapy

Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma

Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)

Allergen Immunotherapy for the prevention of respiratory allergy

Allergen Immunotherapy in the Republic of Kazakhstan

Allergen immunotherapy

Allergen immunotherapy (AIT) in pregnancy, focus on the use of carbamylated monomeric allergoid

Allergen immunotherapy 01

Allergen immunotherapy 02

Allergen immunotherapy 03

Allergen immunotherapy 04

Allergen immunotherapy 05

Allergen immunotherapy 1

Allergen immunotherapy 2

Allergen immunotherapy 3

Allergen immunotherapy 4

Allergen immunotherapy 5

Allergen immunotherapy 6

Allergen immunotherapy 7

Allergen immunotherapy and Anaphylaxis

Allergen immunotherapy and biologicals: when and how

Allergen immunotherapy for airway allergy

Allergen immunotherapy for allergic disease: Indications and contraindications

Allergen immunotherapy in childhood: setting up the therapeutic goals

Allergen immunotherapy in food allergy, what’s new?

Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19

Allergen specific IgE is a stronger predictor of remission following Peanut Oral Immunotherapy in children aged 1-10 years

Allergen-specific IgE-blocking antibodies in the course of allergen immunotherapy

Allergen-specific IgE/IgG4 ratio as biomarker of allergen immunotherapy efficacy in house dust mite-sensitized allergic rhinitis

Allergen-specific immunotherapy based on purified and modified Fel d 1 allergen from cat dander

Allergic, but still want them: A Mix Pet Dander Immunotherapy

Allergy Therapeutics – Setting a new standard for grass subcutaneous immunotherapy

Alpha-gal syndrome in patient infected with Ascaris lumbricoides: a possible causal role of exposure to parasitic antigens for galactose-a-1,3-galactose sensitization and elicitation of clinical reactivity

Alterations in B cell memory induced by house dust mite allergen immunotherapy

An exotic anaphylaxis in the mediterranean: due to a clinical case

An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)

Analysis of clinical and anamnestic risk factors of bronchial asthma in children

Analysis of epinephrine use during peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1 to 3 years

Analysis of immunological and cellular tolerance biomarkers during bee venom immunotherapy

Analyzing Factors Influencing Adherence to Classify Adherence Levels in Patients Treated with Allergen Immunotherapy

Antioxidant pine nut protein hydrolysate as a therapeutic oral immunotherapy agent in a murine model of pine nut allergy

Application of allergen standardization in allergen-specific immunotherapy (AIT)

Artificial Intelligence approaches for advancing drug development and clinical applications

Artificial intelligence and precision immunology: pioneering biomarker discovery in allergen immunotherapy

Artificial intelligence-based B-cell epitope peptide immunotherapy alleviates chitin-binding protein-induced type 2 airway inflammation in Blomia tropicalis

Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma

Assessing long-term clinical and immunological evolution of Portuguese Patients with LTP Syndrome

Assessing the Clinical Performance of a Basophil Activation Test for Allergic Disorders under IVDR Compliance

Assessing the role of specific IgA in prophylactic sublingual immunotherapy for peanut allergy: A Brown Norway rat study

Assessment of the Efficacy of Specific Immunotherapy After a Long Break in Asthmatic Patients

Asthma phenotype markers did not affect allergen immunotherapy effectiveness

AstraZeneca – Transforming severe asthma respiratory care: the clinical experience

Atypical clinical cases of fixed drug eruptions due to radiological contrast media

Audit of Peanut Allergy Patients Eligible for Oral Immunotherapy (OIT) in a Paediatric Cohort at Galway University Hospital (2020-2023)

Autoantibodies to interferon-gamma: clinical features, treatment outcomes, and in-vitro monitoring of disease

B Cell Repertoires and Phenotypes in Food Allergy and Oral Immunotherapy

Baseline Predictors of Multicomponent Clinical Remission Following Dupilumab Treatment in Patients With Moderate-to-Severe Asthma

Baseline characteristics and main clinical outcomes of patients receiving tezepelumab in the framework of use in Special Situations prior to commercialization in Spain (T-ROSS Study)

Basic and clinical immunology

Basophil Activation by Digested Peanut Protein Enhances the Prediction of Clinical Reactivity and Delayed Responses in Peanut Allergy

Basophil activation test as a predicting tool for effective Pru p 3 sublingual immunotherapy response in lipid transfer protein allergy

Best candidate for allergen-specific immunotherapy

Beta-Lactam Hypersensitivity: 5-year characterization of patients evaluated at the University of Chile Clinical Hospital

Biologicals as adds on in oral immunotherapy for IgE mediated food allergy

Biomarkers of tolerance in clinical trials

Biostatistics in allergy and clinical immunology: reasons for concern and editorial recommendations

Birch Rust: Unveiling a Novel Fungal Allergen in Seasonal Airway Allergy Symptoms – Insights from the First Clinical Cohort in Northern Norway

Blocking antibodies from food immunotherapy unravelled at the molecular level

Brazilian Anaphylaxis Registry: Main triggers, clinical manifestations and treatment

Build-Up of Wasp Venom Immunotherapy with Alutard-Depot SQ during Supply Shortage: A Retrospective Case Series

Bumblebee venom allergy as an emerging occupational allergy: safety and efficacy of bumblebee venom immunotherapy in a large single-center cohort

Carry-over effect of 300 IR house dust mite sublingual immunotherapy tablet and relationship with disease activity: a post hoc analysis

Challenge accepted: Results from the pivotal Grass Phase III clinical trial

Challenges in food allergen immunotherapy

Changes in IgG4 and IgE epitope binding profile are greater with sublingual than oral immunotherapy in milk-allergic children, and correspond to efficacy outcomes

Changing Allergen Immunotherapy Practice Profiles in Mexico

Characterising Adult Legume Allergy in Clinical Practice

Characterization of Allergenic Proteins in Ginger: A Clinical Case of Anaphylaxis

Characterization of Allergenic Proteins in Pine Nut: A Clinical Case Study

Characterization of Treatment-Refractory Chronic Urticaria: A Large-Scale Retrospective Analysis of Clinical and Laboratory Parameters

Characterization of the clinical phenotype of patients with CSU treated with cyclosporin alone or combined with omalizumab

Characterization patient’s cohort with drug reaction with eosinophilia and systemic symptoms during the years 2022 and 2023 at University of Chile Clinical Hospital

Childhood asthma: From epidemiology to implementation in clinical practice

Childhood lung function trajectories: Implementation at clinical and population level

Childhood mastocytosis: challenges in clinical practice

Chronic Spontaneous Urticaria Patients in Latvia: Epidemiological and Clinical Characteristics

Chronic spontaneous urticaria with wheals, angioedema, or both: Differences in clinical characteristics, biomarkers and treatment response

Chronic spontaneous urticaria: latest clinical developments

Chronic urticaria across the ages: clinical features, comorbidities, and treatment response

Clinical Application of Exosome KL-6 Detection in Respiratory Diseases

Clinical Characteristics and Natural Course of Children with Dermographic Urticaria

Clinical Characteristics and Natural Course of Chronic Inducible Urticaria in a Pediatric Cohort

Clinical Characteristics and Predictors in Patients with Difficult-to-Treat Asthma

Clinical Characteristics and Treatment Response of Eosinophilic Esophagitis in Pediatric Patients: A Descriptive Study from a High-Complexity Colombian Institution

Clinical Characteristics of Chronic Urticaria in Adults Under 45 Years Old with Vitamin D Insufficiency

Clinical Characteristics of Patients with Severe Asthma by Different Elevated Biomarkers Classifications: Patients from Spain in the ISAR Registry

Clinical Characteristics, Diagnosis, And Treatment Outcomes In Chronic Cold Urticaria: Insights From A 15-Year Study

Clinical Characterization of a Group of Patients with Suspected Hereditary alpha-Tryptasemia

Clinical Course of Hereditary Angioedema Patients Transitioning off Androgens

Clinical Effectiveness of Tezepelumab on Upper and Lower Airway Symptoms in Patients with Asthma and Co-morbid Nasal Polyposis

Clinical Evaluation of Allergic Diseases in Pediatric Patients Diagnosed with Cutaneous Mastocytosis: A Retrospective Study

Clinical Evaluation of Alternaria alternata Extract Used for Skin Prick Test in Diagnosis of Alternaria alternata Allergy

Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs

Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs

Clinical Features of Pediatric Cases Followed with the Diagnosis of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Single-Center Experience

Clinical Impact of Long-Term Prophylaxis De-escalation with Lanadelumab in Hereditary Angioedema Type I and II

Clinical Implication of Neutrophil Phenotypes in Chronic Rhinosinusitis With Nasal Polyps

Clinical Management

Clinical Manifestations of Dust Mite Allergy in Children Under 18 Years of Age

Clinical Outcomes Of Dental Procedures In Patients With Hereditary Angioedema

Clinical Outcomes and IgA Deficiency in Pediatric Patients: A Retrospective Study in a Tertiary Hospital

Clinical Outcomes of Neuromuscular Blocking Agent Rechallenge Based on Skin Prick Test in Patients with Intraoperative Anaphylaxis

Clinical Pathway on direct drug provocation testing

Clinical Phenotype in allergy to Brassicaceae and in-vitro diagnostic approaches

Clinical Remission in Asthma and its Correlation with Nasal Comorbidities

Clinical Simulation in a paediatric refractory anaphylaxis: Lessons from a simulation

Clinical Trials on Airways Diseases

Clinical Trials on Dermatology

Clinical Validation of a Novel Kinin Biomarker Assay for Characterisation of Bradykinin-Mediated Pathologies in US Subjects with Hereditary Angioedema

Clinical and Allergological Profile of Children and Adolescents With Ocular Allergy In Brazil

Clinical and Epidemiological insights into generalized bullous fixed drug eruption (GBFDE) in African TB HIV endemic settings: A comparison with Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)

Clinical and Healthcare Resource Use in Patients with Asthma and Low-Eosinophil Counts

Clinical and Immunologic Phenotype of Patients with SMAD4 Gain-of-Function Mutations

Clinical and Inflammatory Characteristics of Occupational Asthma Caused by Persulfate Salts in Hairdressers: A Multicenter Cohort Study

Clinical and Translational Allergy

Clinical and Treatment Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps by Treating Physician Specialty: Results from an EU Chart Review Study

Clinical and atopic features of patients with primary eosinophilic colitis: an Italian multicentre study

Clinical and histological differences between choanal polyps in children and adults: analysis of a 15-year series of patients treated at our institution

Clinical and histopathologic response following empiric food elimination diet in children with eosinophilic gastritis

Clinical and immunological characterization of patients with allergy to Hymenoptera venom in a county Hospital of Tolosaldea, Gipuzkoa, Spain

Clinical and laboratory features of children at risk of local allergic rhinitis

Clinical and laboratory features of patients with non-hereditary angioedema – a preliminary report of 37 cases

Clinical and molecular profiles in patients allergic to Amaranthaceae

Clinical aspects of chronic urticaria

Clinical case discussion in atopic dermatitis

Clinical case of development anaphylaxis to cow`s milk proteins

Clinical case: Patient with Inherited epidermolysis bullosa and eosinophilic esophagitis

Clinical cases of non-IgE mediated food allergy: from pratice to theory

Clinical characteristics and risk factors of allergic diseases in children after liver transplantation

Clinical characteristics and unmet treatment need in patients with hereditary angioedema treated with long-term prophylaxis: A real-world survey

Clinical characteristics of eosinophilic esophagitis and gastroenteritis in Korean children: a single-center study

Clinical characteristics of food anaphylaxis in patients with hereditary alpha-tryptasemia

Clinical characteristics of mastocytosis in Poland based on Polish Registry of Mastocytosis

Clinical characteristics of patients with hypereosinophilic syndrome and the efficacy of anti-IL-5 therapy: a retrospective cohort study

Clinical effects of dupilumab in patients with rhinosinusitis, nasal polyposis, and severe uncontrolled asthma with t2 phenotype, after 12 months of treatment

Clinical evaluation of the efficacy of profilin isolated from Acanthamoeba as an allergen

Clinical evidence of a Reversed Enzyme Immuno Assay and an Allergy Lateral Flow Assay for the quantitative determination of specific IgE to different allergens

Clinical experience with newer systemic treatment for moderate to severe atopic dermatitis in children and adolescents: a single-centre study

Clinical experience with targeting TSLP: first-line biologic use

Clinical experience with targeting TSLP: reducing patient burden of disease

Clinical features and Progress of Diagnosis and Therapy of Hereditary Angioedema in China: A Systemic Review of Published Cases

Clinical features and potential markers of disease in idiopathic non‑histaminergic angioedema, a real‑life study

Clinical features of anaphylaxis in Greek children aged 0-16 years: A 2-year nationwide multicenter registry

Clinical features of patients diagnosed with alpha- gal syndrome referred to an allergy clinic in Sri Lanka

Clinical history seen with different hypersensitivity reactions

Clinical impact of Immune mechanisms driving asthma

Clinical implications of biologic therapies in comorbid severe asthma and CRSwNP

Clinical improvement with mepolizumab after endoscopic nasal polyposis surgery in a patient with polyposis

Clinical manifestations and cross-reactions with cockroaches of Formosan subterranean termite (Coptotermes formosanus) and Asian subterrabea termite (Coptotermes gestroi)

Clinical manifestations and outcomes of IgE-mediated food allergy in children

Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes

Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Clinical performance of IgE Quaternary Ammoniums, Atracurium, Rocuronium and Suxamethonium for the diagnosis of an allergy to curares

Clinical perspectives in chronic urticaria: from etiology to severity and prognosis

Clinical phenotypes of Common variable immunodeficiency disorders (CVID) among adult Egyptian patients

Clinical phenotypes of nonsteroidal anti-inflammatory drug hypersensitivity

Clinical presentations

Clinical profile and management of pediatric hereditary angioedema in resource constrained settings: our experience from a single centre in North India

Clinical profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)

Clinical profile of children and adolescents with ocular allergy in Brazil

Clinical relevance of secondary sensitizations to indoor allergens in patients with persistent allergic rhinitis in a region with high prevalence of dust mite allergy

Clinical remission in food allergy: How close are we?

Clinical remission of severe asthma: 5-year follow-up

Clinical scenarios of allergic diseases with underlying mastocytosis

Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study

Clinical significance of a basophil activation test for Japanese beekeepers naturally sensitized to honey bee venom

Clinical trials

Clinical trials in food allergy

Clinical trials in immune tolerance

Clinical trials on Asthma and Rhinitis

Clinical validation of an environmental exposure chamber in the diagnosis of allergic respiratory disease

Clonal mast cell disorders, allergy to hymenoptera venom and venom immunotherapy – our experience

Cluster immunotherapy for bee venom in delayed levo-tyrosine formulation with short protocol

CoMiSS™ data in presumed healthy infants, how does this strengthen our clinical practice?

Cold-Induced Anaphylaxis: New Perspectives on Clinical and Genetic Characteristics

Comparative analysis and evaluation of clinical and stewardship implications of parent reported antibiotic allergy labels within paediatric care

Comparison of baseline clinical characteristics of chronic spontaneous urticaria patients receiving omalizumab, with and without concomitant angioedema

Comparison of basophil activation by different yellow jacket venoms from three continents and venom used in immunotherapy

Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children

Component-Resolved Diagnosis and Clinical Profiles of Anisakis Allergy in Japan

Comprehensive Analysis of Kiwi Allergy: Sensitization Patterns, Clinical Profiles, and Molecular Patterns using ISAC Testing

Comprehensive study on clinical characteristics of acute urticaria

Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis

Cracking the Code: Immunological Changes Leading to Raw Egg Tolerance During Immunotherapy with Cooked Egg

Cross-Country Variations in NSAID Hypersensitivity: A Comparative Study of Clinical Presentations and Phenotypes in Spain and Turkey

Cross-tolerance to cashew by prophylactic sublingual immunotherapy with different tree nuts in Brown Norway rats

Current knowledge on venom allergen immunotherapy

Cytometric biomarkers, clinical phenotype, and complications of common variable immunodeficiency – study from specialised Centre for primary immunodeficiencies in Martin, Slovakia

DBV Technologies – Epicutaneous route: an innovative potential approach to food immunotherapy

DRAGO Application: Implementing Adherence and to House Dust Mite Allergen Immunotherapy

Dairy products and its clinical relevance in a series of Alpha gal allergic patients

Deciphering the Clinical Significance of Very-High IgE Levels (≥1000 U/mL) Among Adult Patients: a Population-based Study of 283,406 Subjects

Decreased frequency and severity of oral immunotherapy induced gastrointestinal eosinophilic reactions following revisions in treatment protocol

Delving deeper in allergen immunotherapy

Demystifying the fear of lack of adherence to sublingual immunotherapy (SLIT)

Der p 23 quantification in a HDM allergoid and its clinical relevance

Description of Clinical Features and Triggers in Hereditary Angioedema Attacks Associated with Coagulation Factor XII Mutations

Descriptive Study on the Evolution of Patients Treated with Oral Immunotherapy (OIT) Using Pasteurized Egg White at the Fundación Alcorcón University Hospital

Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre

Descriptive bias in the clinical history of adverse drug reactions in children

Descriptive study of the evolution of patients after oral immunotherapy with milk at the Hospital Universitario Fundación Alcorcón

Designing Modified Variants of Ara h 1 and Ara h 2 for Safe and Effective Immunotherapy

Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients

Developing and validating clinical models to identify candidates for allergic rhinitis pre-exposure prophylaxis

Development and Validation of a Clinical Risk Score to Predict Pediatric Atopic Dermatitis in Utero

Development and implementation of an intelligence platform for management of allergen immunotherapy in China

Development of Eosinophilic Esophagitis in a Child with Multiple Food Allergies: The Role of Omalizumab, Oral Immunotherapy and Dietary Incompliance: A Case Report

Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema due to C1 Inhibitor Deficiency

Development of a thermosensitive poloxamer formulation designed to provide a controlled release of the active pharmaceutical ingredient in birch pollen allergen immunotherapy

Dietary Intervention in LTP allergic patients: clinical response

Dietary feasibility and adherence to an immune supportive diet in children with a peanut or nut allergy; results from a subpopulation of the randomized controlled clinical DIAMETER study

Dietary outcomes following oral immunotherapy for cows milk allergy: Results from the SOCMA Study

Differential study of whole genome expression profiles of peripheral blood mononuclear cells in children with dust mite specific immunotherapy for asthma

Discovering new horizons in allergen immunotherapy

Distribution of Baseline Type 2 Inflammation Characteristics in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Biologic Clinical Trials: A Comparative Assessment

Drug Allergy: Implementing the Latest EAACI Guidelines in Clinical Practice

Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity

Dupilumab Treatment is Associated with Clinical Improvement and a Shift towards a health-associated Nasal Passage Microbiota in Diffuse Type 2 Chronic Rhinosinusitis

EAACI & NIAID Joint Symposium : Harnessing the Potential of Endotyping Data to Predict Clinical Outcomes in Allergic Disease

EFFECTIVENESS AND SAFETY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY WITH Pru p3 EXTRACT IN PATIENTS WITH LTP ALLERGY

EGPA: a clinical case in real life

Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients

Early immunotherapy with aeroallergens and impact on future allergy

Early inflammatory reactions in mice after immunotherapy with an allergen microcrystalline tyrosine adsorbate

Effect of 300 IR house dust mite sublingual immunotherapy tablet in paediatric patients and relationship with disease activity

Effect of Dupilumab on Radiological Remission in Patients with Chronic Rhinosinusitis with Nasal Polyp: A step Toward Clinical Remission

Effect of Metformin on allergen specific immunotherapy

Effect of allergen – specific immunotherapy on PFS symptoms

Effect of allergen immunotherapy on quality of life

Effect of allergen specific immunotherapy on PFS symptoms

Effect of sublingual immunotherapy on allergic rhinitis: Real-life data analysis

Effectiveness and Safety Study of Subcutaneous Immunotherapy for Respiratory Allergy to Dermatophagoides and Lepidoglyphus Destructor

Effectiveness and safety of Venom ImmunoTherapy (VIT) with “Rapid Cluster” induction protocol

Effectiveness of House Dust Mite Subcutaneous Immunotherapy on Co-existing Allergen Symptoms in Polysensitized Patients with Allergic Rhinitis: A Multicenter Retrospective Analysis

Effectiveness of sublingual immunotherapy in patients with atopic dermatitis allergic to house dust mite: an open label extension study

Effectivity and serological correlation analysis in patients undergoing their first year of mixed subcutaneous immunotherapy for dust mites and cat

Efficacy Study on Intratonsillar Immunotherapy for Patients with Allergic Rhinitis Induced by House Dust Mites (Tonsil-AIT)

Efficacy and Safety of Hymenoptera Venom Immunotherapy

Efficacy and safety of HDM-specific subcutaneous immunotherapy on atopic dermatitis

Efficacy and safety of sublingual immunotherapy for mite in children and adolescents with AR

Efficacy and safety profile of immunotherapy for multiple allergens in polysensitized patients with allergic rhinitis: a systematic review and meta-analysis

Efficacy of House Dust Mite Immunotherapy in Chinese Allergic Rhinitis Patients with Diverse Sensitization Patterns: A Multicenter Study

Efficacy of virus-like particle (VLP)-based immunotherapy in a mouse model of HDM allergy

Egg Allergy in Pediatric Patients: Clinical Profiles, Sensitization and Dietary Implications

Emerging insights into food allergy mechanisms and clinical management

Endpoints in clinical trials

Eosinophilic esophagitis: Exploring local responses, immune mechanisms, and clinical diversity

Eosinophilic esophagitis: clinical approach

Eosinophilic systemic diseases: clinical characterization and efficacy of anti il5/il5-r therapy in a single center italian cohort

Epicutaneous Allergen Administration with Microneedles as a Novel Method of Immunotherapy for House Dust Mite (HDM) Allergic Rhinitis

Epicutaneous Immunotherapy : from mechanism to efficacy

Epicutaneous Immunotherapy with Peanut Allergy

Epicutaneous food allergen immunotherapy

Epidemiology and Clinical Features of Fish Allergy

Epidemiology and clinical management of drug allergy

Epitope Analysis and Mutation Design in Jug r 1 for Hypoallergenic Walnut Immunotherapy

Epitope specific antibody profiling and future clinical applications in food allergy

Erythematous-papular rash due to pseudoephedrine allergy: description of a clinical case

Evaluation Of Clinical Features Of Pediatric Patients with Steven Johnson Syndrome/Toxic Epidermal Necrolysis: A Single Center Experience

Evaluation of Clinical and Demographic Characteristics in Children with Aero-Allergen Sensitization: A Study Based on Skin Prick Test Results

Evaluation of Pediatric Patients with Suspicion of Beta-Lactam Allergy: 5-Year Clinical Experience of Erciyes University Pediatric Allergy Unit

Evaluation of Sublingual Immunotherapy for Cat Allergy: Results from a Non-Interventional Study

Evaluation of auditory function in children with allergic rhinitis treated with specific immunotherapy

Evaluation of the IgEs amount and basophil activity changes during walnut oral immunotherapy

Evaluation of the clinical benefit of a pollen and allergy app in Augsburg, Southern Germany: a stratified, controlled intervention study

Evaluation of the efficacy, adverse effects, and cost-effectiveness of sublingual immunotherapy with dominant allergens for allergic rhinitis due to respiratory allergens in adults and children

Evaluation of the tolerability of the administration of subcutaneous immunotherapy in a cluster schedule, in patients with rhinoconjunctivitis and/or asthma with sensitization to Olea europaea with or without sensitization to grasses

Evaluation of total Immunoglobulin D in sublingual immunotherapy for allergic rhinitis

Evolution of pediatric patients with casein-specific IgE values>100 KU/L undergoing cow’s milk oral immunotherapy

Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP

Exacerbation of eosinophilic esophagitis in a child with seasonal allergic rhinitis during sublingual immunotherapy

Expansion of allergen-specific type 2 memory B cells with an altered phenotype after immunotherapy for bee venom or ryegrass pollen allergy

Experience with ALUTARD SQ Immunotherapy in Patients Allergic to Hymenoptera Venom

Exploration of clinical outcomes for children with and without an antibiotic allergy reviewed by the Children’s Antimicrobial Stewardship Program: A retrospective cohort study

Exploring the Protective Potential: Subcutaneous Immunotherapy associated with C. acnes as a reductor of COVID-19 Severity in Older Patients – A Single-Center Observational Study

Exploring the clinical management of Eosinophilic Esophagitis

Exposure-adjusted safety of peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1-3 years (POSEIDON trial)

Extensive allergic contact dermatitis with distant facial and symmetrical intertriginous involvement following application of antiseptic dexpanthenol cream to the left forearm: An unusual clinical presentation

FRIENDLY TREE NUT AND SESAME ORAL IMMUNOTHERAPY PROTOCOTOLS (ALPEDIA-NOITs)

Factors associated with higher serum IgG4 response in children treated with allergen immunotherapy

Fecal IgE in Peanut Allergy: Pioneering Evidence and Clinical Implications

Field Stings in Patients Undergoing Hymenoptera Venom Immunotherapy in a Healthcare Area of Central Spain

Fixed-Dose Oral Immunotherapy for High-Threshold Food Allergy: Efficacy and Safety in Real-World Practice

Flash talks on Allergen Immunotherapy 1

Flash talks on Allergen Immunotherapy 2

Flash talks on Allergen Immunotherapy 3

Flash talks on Allergen Immunotherapy 4

Flexible and Safe Oral Immunotherapy (OIT) Regimen Using Home Boiled Nut Broths (HBNB)

Food Allergy in Clinical Practice

Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring

Food-allergen immunotherapy : how do I get started?

Food-induced Anaphylaxis in Children: Triggers and Clinical Characteristics by age groups

Four-Year Analysis of the Incidence and Clinical Features of Perioperative Hypersensitivity Reactions in the Allergy-Anaesthesia Unit, Universitary Hospital Cruz Roja

From allergen molecules to allergy management: can molecular diagnosis improve allergen immunotherapy efficacy?

Frontiers in Allergen Immunotherapy: evidence from clinical trials

GSK – Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP

Global Stage Session 3 – Successes and challenges of Immunotherapy

Gut Microbial Bile and Amino Acid Metabolism Associate with Peanut Oral Immunotherapy Failure

HAE On-demand Clinical Trial Landscape

HAE with normal C1Inh (HAE-n C1INH) and spontaneous mast cell AE (AE-MC): clinical similarities and differences

Harmonizing clinical outcomes in food allergen immunotherapy: COFAITH EAACI Taskforce

Has climate change already impacted the epidemiology of allergic sensitisation in the UK and how might it affect clinical allergy?

Health-Related Quality of Life and Clinical Characteristics in People Living with Hereditary Angioedema Prescribed Long Term Prophylaxis Alone and On-Demand Treatment Alone

High degree of desensitization after one year of early-life peanut oral immunotherapy – SmaChO Randomized Controlled Trial

High degree of sustained unresponsiveness and safety after three years of slow up-dose peanut oral immunotherapy in toddlers – results from the SmaChO study (Small Children Oral Immunotherapy)

Highlights of EAACI Guidelines: Latest Developments and Clinical Applications

Highlights of EAACI Task Forces: Bridging Innovation and Clinical Practice

House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents

How allergists around the world perceive innovation in the context of allergen Immunotherapy AIT: an international survey

How can I use food allergy diagnostic tools in my daily clinical practice?

How effective and safe venom allergen immunotherapy is in children

Hymenoptera venom immunotherapy with 210 minutes Ultra-Rush protocol: patient profile and potential risk factors for systemic reactions

Hypersensitivity Reactions to Iodinated and Gadolinium-Based Contrast Media: Clinical and Epidemiological Insights

Hypersensitivity Reactions to Oxaliplatin and Carboplatin: Clinical Features and Cross Reactivity

ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy

INTERESTING FACT: Delayed systemic allergic reactions to corticosteroids: Clinical symptoms y cross-reactivity

Identification of the optimal immunotherapy via CAP Inhibition in Vespa velutina anaphylaxis patients

Identifying KIT D816V Mutation in Patients With Evidence of Systemic Mast Cell Activation (MCA) and Enriched for Hereditary Alpha-tryptasemia (HaT): Results From the PROSPECTOR Clinical Trial

IgE High-Affinity Receptor Expression as a Predictive Biomarker for Oral Immunotherapy Outcomes in Severe Egg and Milk Allergies

IgE profiles and clinical reactivity pattern in plant-food allergy

IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens

Immediate hypersensitivity reactions to corticosteroids: Clinical symptoms and cross-reactivity

Immune Skewing in pediatric asthma – clinical consequences

Immune mechanisms of food immunotherapy

Immunologic profile and safety of milk oral immunotherapy in children with severe cow’s milk allergy – a series of cases

Immunology in clinical practice

Immunophenotypes of Food Allergy and Responses to Immunotherapy Across the Life Course

Immunotherapy for LTP allergy

Immunotherapy for food allergy. What’s new?

Immunotherapy from patient and epidemiological study perspective

Immunotherapy in Food allergies : New frontiers

Immunotherapy in childhoood asthma: is it worth it?

Immunotherapy in food allergy

Immunotherapy in the clinic

Impact of Cooking Methods on Egg Allergenicity: Clinical Insights and Protein Profiling

Impact of Immunogenicity on Clinical Outcomes in Patients from a Severe Asthma Unit Treated with Mepolizumab

Impact of Security Measures Implementation in Subcutaneous Allergen Immunotherapy Administration at a Pediatric Hospital in Mexico

Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset

Impact of allergic rhinitis activity on the effect of 300IR house dust mite sublingual immunotherapy tablet in adolescent patients

Impact of different prophylactic sublingual immunotherapy regimes on peanut allergy prevention in Brown Norway rats

Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study

Impact of liquid sublingual immunotherapy with mixed pollen allergens on asthma prevention in polyallergic patients: results from the real-world EfficAPSI study

Impact of overweight and obesity on clinical remission and Response to Biologics in Severe Asthma Patients

Impact of participant baseline factors on exposure-adjusted incidence of treatment-related adverse events during peanut oral immunotherapy

Impact on sexual health of clinical control in atopic dermatitis

Implementing and optimising advancements in practice – real-world clinical cases

Inborn errors of immunity: Increasing awareness in clinical practice

Increased Inhibitory Surface Marker PD-1 Expression in CD4+T Cells and Th2+T Cells in Allergen-specific Immunotherapy

Increased incidence of suspected clindamycin hypersensitivity reactions in pediatric patients due to its expanded use in clinical practice

Increased the serum Blomia tropicalis antibody levels in children with Dermatophagoides pteronyssinus immunotherapy

Indefinite immunotherapy with different extracts in systemic mastocytosis

Individual Differences in Response to Dust-Mite-Allergen Specific Immunotherapy in Allergic Rhinitis: A Meta-analysis of Randomized Controlled Trials

Innovations and Emerging Therapies in Food Allergy: Bridging Research and Clinical Practice

Innovations in Food Allergy Immunotherapy

Insights from the European registry of anaphylaxis: recurrent anaphylaxis cases and clinical implications.

Interim safety review of PVX108 peptide immunotherapy in an ongoing Phase 2 trial in peanut-allergic adolescents and children

Interpreting clinical and laboratory signs of mastocytosis

Intralymphatic immunotherapy of allergic rhinoconjunctivitis with grass allergoid microcrystalline tyrosine adsorbate produced reduced medication use and symptoms: a double-blind placebo-controlled trial

Intralymphatic immunotherapy with aluminium hydroxide based grass allergen reduced medication use in patients with allergic rhinoconjunctivitis: a double-blind randomized placebo-controlled trial

Intravenous immunotherapy with Der p 1-containing nanoparticles alleviates allergic response in a murine model of allergic rhinitis

Investigation Of Treatment Responses And Clinical Characteristics Of Patients With The Late-Onset Asthma Phenotype Under Biological Treatment

Involving patients in the research process improves the clinical resolution of trial effect

Ionis Pharmaceuticals – Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options

Is milk oral immunotherapy using a home up-dosing protocol a viable and safe treatment for the older milk allergic child?

Kabuki syndrome: unmasking the clinical and immunological profile in pediatric patients

Key clinical messages from mechanistic studies in food allergy

Kinetics of IgG4 after Vespula venom immunotherapy administered with an ultra-rush protocol

Kratom-induced anaphylaxis revealed Monoclonal Mast Cells of Clinical Significance

Local allergic rhinitis in paediatric patients: prevalence and clinical outcomes in nasal allergen challenge

Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma

Long-term Follow-up After Peanut Oral Immunotherapy During Preschool Years: Lessons from the IMPACT Trial

Long-term efficacy and re-sting outcomes following venom immunotherapy discontinuation: A 978-patient analysis

Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics

Low dose oral immunotherapy for children with severe cow’s milk allergy

Machine Learning-Based Analysis of Clinical and Laboratory Features Predicting Malassezia-specific IgE Elevation in Dermatological Disorders

Machine Learning-Based Prediction of Desensitization Success in Oral Immunotherapy for Hen’s Egg Allergy in Children

Management of Eosinophilic Esophagitis as a side effect of food oral immunotherapy

Managing Platinum Salt Hypersensitivity: Insights from a Year of Clinical Experience

Mapping the Patient’s Journey Prior to Allergen Immunotherapy

Mastocytosis in Children: Clinical Challenges and Therapeutic Approaches

Mepolizumab significantly reduces clinical interventions in the management of patients with CRSwNP: post hoc analysis of SYNAPSE using a composite endpoint

Mepolizumab simultaneously improves clinical outcomes in severe CRSwNP and asthma in the SYNAPSE study: Focus on global airway disease

Microneedles-based transdermal allergen specific immunotherapy protects against gliadin induced anaphylaxis in a mouse model

Minimal persistent inflammation in chronic spontaneous urticaria patients with clinical remission

Minimum resources to run an immunotherapy clinic safely

Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure

Modulation of B cell memory responses by house dust mite allergen immunotherapy

Modulation of allergen-specific type 2 memory B cells over the course of 18 months sublingual immunotherapy for house dust mite allergy

Molecular IgE testing in clinical routine: choosing wisely

Molecular Profiling of Banana Allergens: Insights from Clinical Cases

Molecular allergy diagnostics in pediatric clinical practice

Molecular diagnostic results of patients with impaired Th17 T-cell count and clinical suspicion of Hyper-IgE syndrome

Molecular tools in support to walnut oral immunotherapy

Monitoring response to immunotherapy

Moving Beyond Control to On-Treatment Clinical Remission

Mucosal delivery of allergen-specific immunotherapy with vaccine adjuvants suppresses allergic disease through both humoral and cellular immune mechanisms

Murine IgG1 corresponding to human IgG4 increased by subcutaneous immunotherapy suppressed activation of group 2 innate lymphoid cells

Murine IgG1 increased by subcutaneous immunotherapy suppressed development of allergic asthma

NOVEL MULTI-NUTS ORAL IMMUNOTHERAPY PROTOCOLS (ALPEDIA-NOITs)

Nasal Allergen Challenges in the clinical setting: Experience of a centre

Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)

Navigating Oral Food and Drug Provocation Tests: Assessing Tolerance and Safety in Clinical Settings

Nebulized inhaled epinephrine versus epinephrine autoinjector for the treatment of food-induced anaphylaxis in young children – a randomized controlled clinical trial

New clinical nomenclature for CRS

New directions in immunotherapy and vaccinology

New grading of Vernal keratoconjunctivitis based on clinical profile of 1049 Vernal Keratoconjunctivitis patients

New insights on allergen immunotherapy

New mechanisms for the induction of tolerance by Oral Immunotherapy

Nitial Experience of Long-Term Prophylaxis with Lanadelumab for Hereditary Angioedema in China: a Clinical Observation

Novel allergen immunotherapy strategies

Nut immunotherapy – Is it ready for prime time?

Nuts Allergy in Children: A Single-Center Retrospective Analysis of Prick-to-Prick Test Results, Clinical Course, and Tolerance Status

OAS – Clinical Trial Session 3

Oat Allergy in a Young Adult: Allergenic Protein Profiling and Clinical Implications

Ocular Cicatricial Pemphigoid, clinical and immuno-pathological aspects, is there an association with elevated IgE?

Omega 5 Gliadin positive presentation clinical profile

One-strength dose escalation using a birch pollen allergoid for subcutaneous immunotherapy is safe and well-tolerated in children, adolescents and adults

One-year follow-up of children who achieved sustained unresponsiveness following early oral immunotherapy for various allergens

Open source release of the Allergen Chip national French database of clinical and multiplex IgE data

Optimal endpoints for clinical trials

Oral Immunotherapy

Oral Immunotherapy for Adults with Food Allergies

Oral Immunotherapy for Fish Allergic Children

Oral Immunotherapy with omalizumab in an adult patient with severe milk and egg allergy

Oral immunotherapy (OIT) in walnut and hazelnut co-allergic patients: ELISA inhibition studies to direct treatment approach

Oral immunotherapy decreases expression of pro-inflammatory genes upon re-exposure to allergen in egg allergic children

Oral immunotherapy in cow’s milk allergic patients

Oral immunotherapy protocols for milk / egg

Oral immunotherapy to hazelnut in children: a single-center retrospective study in an Italian cohort

Outcomes of Bee Re-sting After Cessation of Venom Immunotherapy

Outcomes of low-dose peanut food challenges in preschoolers when initiating peanut oral immunotherapy

Ovalbumin-loaded nanoparticles for allergen specific immunotherapy

Overview of Asthma On-Treatment Clinical Remission Data

Overview of the clinical utility of molecular allergology in food allergy diagnosis

Passive immunotherapy with anti-Bet v 1 mAb

Pathomechanisms and clinical features of CADR

Patient preference: A multinational discrete-choice-experiment (DCE) in pollen allergen immunotherapy (AIT)

Patient-reported outcomes after 5 years of oral immunotherapy for peanut allergy: results from the BOPI (Boiled Peanut Oral Immunotherapy) study

Patients With Moderate-to-Severe Asthma Treated With Dupilumab Are More Likely to Meet Clinical Remission Criteria: Results From the VESTIGE Trial

Patients undergoing immunotherapy with Alternaria alternata: prevalence of asthma and co-sensitization to other allergens

Patterns of peanut ingestion in remission vs desensitized patients after completion of peanut oral immunotherapy at 3-years post-treatment

Peach Allergy in Children: Connecting Molecular Sensitization Patterns to Clinical Severity

Peanut oral immunotherapy has not recuded basophil activation

Peanut oral immunotherapy in toddlers

Performance Analysis of Five Large Language Models, Including GPTo1-Preview, On an Allergy and Clinical Immunology Exam

Perioperative Immediate Hypersensitivity Reactions: First Chilean Cohort Study 2020-2024 Clinical Hospital University of Chile

Persisten severe cow’s milk allergy with successful oral immunotherapy in adulthood

Perspective of healthcare professionals dealing with allergies about the importance and practical experience of clinical coding

Pharmacogenomics and Precision Medicine in Drug Allergy: From Research to Clinical Application

Piperacillin-tazobactam Fever in Children with Cystic Fibrosis: Incidence and Clinical Features

Poloxamer formulation for allergen immunotherapy reduces systemic allergic reactions in a mouse model

Positive HLA-B*13:01 Allele in a Patient with Clinical Diagnosis of Drug Induced Eosinophilia with Systemic Symptoms (DRESS)

Positive effect of a 300IR dosing pump-administered liquid sublingual immunotherapy on allergic disease evolution: Results from the observational, prospective, longitudinal PRACTIS study

Positive impact on quality of life with a depigmented-polymerized house dust mite extract immunotherapy

Positive outcome of the pivotal Phase III study with PQ Grass, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine and Monophosphoryl Lipid A as adjuvant system

Pre & Post Puberty Vernal Keratoconjunctivitis – Similarities & Differences of Clinical Manifestations in 1049 patients

Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score

Predicting treatment response to oral immunotherapy in peanut-allergic children using multi-omics risk scores

Predictors of response to oral immunotherapy

Prescription rates and adherence to bee- and vespid- immunotherapy in Austria – a population-based study

Present and future of allergen immunotherapy

Prevalence and clinical picture of wheat allergy in German children

Prevalence and risk factors of systemic allergic reactions to bee venom among Slovenian beekeepers: implications for public health and clinical practice

Prevalence of allergic sensitization to Quercus ilex and its clinical relevance in pollen food allergy syndrome. Differences between pediatric and adult populations

Profile of patients treated with the 300IR liquid sublingual immunotherapy for cat allergy and perception of treatment effect: Results from a French survey

Prognostic value of specific IgE ratios in the tolerance of oral immunotherapy with egg allergy

Progress in understanding the mechanisms of airborne allergen immunotherapy

Prospective monitoring of clinical outcomes and laboratory markers of hereditary angioedema in patients on long-term prophylaxis with lanadelumab: One-year follow-up

Protein and allergen content variability of peanut-containing products used in oral immunotherapy for peanut allergy

Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites

Protocols for venom immunotherapy in the era of depot formulations

Quinolone Hypersensitivity Investigation in a Clinical Setting

RHINA : Clinical Case Discussion

Raising the Bar in Asthma Management: On-Treatment Clinical Remission

Randomized Controlled Trial of Sublingual Immunotherapy for Egg Allergy

Randomized controlled trial of pancake oral immunotherapy for egg allergy

Rapid clinical and immunological improvement of persistent lymphoproliferative disease in a patient with Activated PI3K Delta Syndrome (APDS)

Rare cases in paediatric allergy clinical practice

Rationale and Design of the ALPHA-SOLAR Clinical Trial of STAR-0215 for the Treatment of Hereditary Angioedema (HAE)

Reactions Due to Accidental Peanut Consumption During Epicutaneous Immunotherapy for Peanut Allergy in Toddlers

Real-World Protective Effects of Epicutaneous Immunotherapy in Peanut-allergic Toddlers

Real-life Non-interventional Post authorization Safety Study with the SQ tree sublingual immunotherapy tablet

Real-life experience of allergen-specific immunotherapy

Real-life experience with long-term oral immunotherapy for nut allergic children: A single center study from Luxembourg

Real-world allergen immunotherapy effectiveness in allergic asthma

Real-world clinical experience with dupilumab use in 33 children with severe atopic dermatitis

Recurrent angioedema with the mutation in the Myoferlin gene. Clinical observations

Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Retrospective Analysis of Fixed Drug Eruptions: Unveiling Clinical Patterns and Identifying Causative Drugs

Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes

Role of sublingual immunotherapy in management of patients with moderate to severe allergic rhinitis; one year study

SPOTLIGHT: A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihis

SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma

Safety Data for House Dust Mite and Pollen Subcutaneous Allergen Immunotherapy in Children: Systemic Reactions and Risk Factors

Safety and Tolerability of Rush Updosing Using a Mugwort Allergoid Extract for Subcutaneous Allergen Immunotherapy

Safety and compliance of sublingual immunotherapy with house dust mite extract in patients with atopic dermatitis for 1 year

Safety and efficacy of a 7-week immunotherapy protocol with aluminum hydroxide adsorbed bee venom

Safety and tolerability of in-season initiation of subcutaneous and sublingual allergen immunotherapy with SQ grass pollen products: a comprehensive review

Safety and tolerance response of a two day rush protocol treatment in immunotherapy using purified Apis mellifera dry Honeybee venom extract

Safety assessment of garadacimab in clinical studies involving patients with hereditary angioedema, idiopathic pulmonary fibrosis, and COVID-19

Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment

Safety of oral immunotherapy in preschool aged children with single and multiple food allergy (the ORKA trial): a prospective intervention study

Safety of subcutaneous immunotherapy with mixtures of two allergens at maximum concentration: 10 year real-world data

Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix

Sanofi Regeneron – On-Treatment Clinical Remission in Upper and Lower Airways: Going Beyond Symptom Control

Seafood-induced anaphylaxis: Frequency, elicitors and clinical phenotypes

Selecting the right immunotherapy for Vespa velutina nigrithorax anaphylaxis: does one treatment fits all?

Selective Facial Angioedema Induced by Propionic Acids: A Clinical Study of NSAID Idiosyncratic Reactions (Type 3a)

Should we be concerned when starting allergen immunotherapy in patients with controlled HIV infection or autoimmune diseases?

Slow oral immunotherapy for food allergy – what evidence do we have?

Small Doses, Big Benefits: The Promise of Low-Dose Oral Immunotherapy

Specific IgE and IgG4 changes in adults undergoing peanut immunotherapy combined with omalizumab

Stallergenes Greer – “Allergen Harmony”: New data for a tailored and sustained food and respiratory immunotherapy effect

Starting with Low-Dose Sesame Food Challenges for Oral Immunotherapy

Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in mite allergic rhinitis patients with concomitant asthma

Storage proteins: clinical and molecular patterns of peanut and tree nut allergy of a pediatric portuguese population

Study design for A multicenter, open label, randomized Study to inveStigate the effIcacy of Subcutaneous immunoTherapy combined with vitamin D3 in children and adolescent patients with allergic rhinitis (ASSIST study)

Study design for efficacy evaluation of subcutaneOus immunotherApy in patients with obstructive Sleep apnea concomitant with allergIc rhinitiS (OASIS study)

Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)

Study of Efficacy of Rush Sub Lingual Immunotherapy (RSLIT) in Cases of Severe Persistent Allergic Rhinitis

Subcutaneous Allergen-specific Immunotherapy in Pediatric Age – a level II hospital experience

Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions

Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe in a pre/co-seasonal treatment regimen – a subgroup comparison

Subcutaneous short-course grass AIT: molecular mechanisms of humoral immune tolerance and translation into clinical efficacy

Sublingual allergen immunotherapy in children with AR

Sublingual dust mite allergen immunotherapy reduces respiratory infections in children with allergic rhinitis

Sublingual immunotherapy for house dust mite allergy induces expansions of allergen-specific memory B cells expressing CD29 and downregulating IL4Rα

Sublingual immunotherapy with Pru p 3 induces DNA methylation changes towards tolerance in dendritic cells from patients with nsLTP allergy

Sublingual immunotherapy with peanut protein extract has an effect in Brown Norway rats sensitised via the skin

Successes and challenges of Immunotherapy

Successes and challenges of Immunotherapy in Poland and EU

Successful immunotherapy with cow’s milk and omalizumab in a 24-year-old patient with extreme cow’s milk allergy

Sulfonamide antibiotic allergy assessment using the SULF-FAST clinical decision tool

Surgical Excision of a Mastocytoma in a Child with Polymorphic Cutaneous Mastocytosis: Clinical and Biochemical Improvement in a Case with Significant Impact on Quality of Life

Sustained and Long-term effect of allergen immunotherapy in local respiratory allergy

Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml

Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis

Systemic allergic reactions to subcutaneous allergen immunotherapy – A single center experience

Systemic reactions to subcutaneous immunotherapy in children

TAPAS – non-inferiority of clinical effectiveness in children compared to adults: interim results of a long-term NIS

Th2 immune responses and clinical outcomes

The BEACON Study: A Phase 1b/2a, Dose Escalation Study of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of the c-Kit Mab Briquilimab in Adults with symptomatic Chronic Spontaneous Urticaria (CSU)

The Clinical Characteristics and Inflammatory Endotypes of Chronic Rhinosinusitis with Nasal Polyps in Southern China: A Multi-Center, Cross Section study

The Clinical Faces of Hereditary Angioedema

The Clinical Faces of Mastocytosis

The Efficacy of Sublingual Immunotherapy in Mild versus Moderate Atopic Dermatitis Among Children with House Dust Mite Allergic Rhinitis

The Impact of Obesity in Asthma and Small Airway Dysfunction: Prevalence, Clinical characteristics, and Predictors

The PAF inhibitor Rupatadine has a positive influence on clinical and laboratory findings in patients with urticarial vasculitis

The Quest for Tolerance in Allergen Immunotherapy

The Role of Oral Food Challenges in Clinical Trials: Necessity or Redundancy?

The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis with and without concomitant asthma – results from a global phase III clinical trial

The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis – results from a global phase III clinical trial

The SQ tree SLIT-tablet is effective and well-tolerated during the tree pollen season (birch homologous group) in children (5-17 years) – results from a global phase III clinical trial

The Sting Challenge Test: a key tool for monitoring the effectiveness of venom immunotherapy

The change in quality of life of adults with food allergy treated with oral immunotherapy

The clinical case scenarios for management of drug allergy: to provoke, treat through, or desensitize

The clinical value of allergen detection panel in Guangzhou, southern China: A big data study based on allergen detection in the past 7 years

The efficacy analysis and immunological changes after Alternaria alternata immunotherapy

The epicutaneous immunotherapy for peanut allergy: most recent results and perspectives

The epicutaneous route: from the concept to potential clinical applications.

The experience from clinical trials

The future of food allergy: Challenging existing paradigms of clinical practice

The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment

The journey to registration: challenges for allergen immunotherapy trials

The overall diet and environmental factors in oral immunotherapy

The safety of an optimal accelerated immunotherapy for allergic rhinitis in adolescent and adult patients in China (PERFECT study)

The successful switch of Hymenoptera venom immunotherapy (VIT) to a different manufacturer

The utility of basophil activation testing in honey bee venom allergy diagnosis and venom immunotherapy

The value of TNF and IL1RN genes in predicting the clinical efficacy of SCIT in children with asthma

Thermo Fisher Scientific – How can I use food allergy diagnostic tools in my daily clinical practice?

Timing in oral immunotherapy : Early vs. Late introduction

Tolerance induction through oral immunotherapy

Trained innate immunity and immunotherapy

Transforming severe asthma respiratory care: the clinical experience

Translating Science into Clinical Impact: The Journey of Allergy Research

Translating clinical definitions of anaphylaxis into patient advice

Translational tools (adaptive trial design, end points in clinical trials and registries) the EAACI Highlights

Treatment Patterns in Patients Who Initiated Dupilumab in a Real-World Clinical Setting: The RAPID Registry

Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre

Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-clinical Murine Model

Two Cases of Multiple Drug Hypersensitivity: Diagnosis and Clinical Management

Two-year Outcomes of Low-dose Oral Immunotherapy for Children with Severe Walnut Allergy

Understanding of mechanisms of food immunotherapy

Understanding the Patient: Their Preferences for Venom Immunotherapy

Unveiling Unique Allergenic Properties Of Rapeseed Oil: A Clinical Case Study

Unveiling clinical patterns in hereditary alpha tryptasemia among anaphylaxis patients

Using the AllergyVax app to increase adherence to allergen subcutaneous immunotherapy

Utility of basophil activation test (BAT) in evaluation of efficacy of venom immunotherapy determined by sting challenge: A systematic review

Validation of a novel serum-based basophil activation test (iBAT) to evaluate efficacy of a pivotal Phase III PQ Grass immunotherapy trial

Variables predicting clinical remission among adults with severe asthma treated with biologic agents

Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life

Venom Immunotherapy in children and adolescents: safety and outcome in a study group from a third level Italian center

Venom allergies : Difficult Cases in Clinical scenarios

Venom immunotherapy in children – do we have an age limit ? (case report)

Venom immunotherapy in mastocytosis

What is new in guideline based clinical practice in anaphylaxis?

When Immunotherapy Strikes Twice: IgE Hypersensitivity and HES as Dual Adverse Effects of Pembrolizumab

Where are we currently in sublingual immunotherapy for food allergy?

Why So Sensitive? Identifying New Allergic Sensitization in Patients On Subcutaneous Immunotherapy (SCIT)

Аllergen-specific immunotherapy in patients with allergic rhinitis

Сytokine profile in patients with allergic rhinitis during allergen-specific immunotherapy with added vitamin D

Сytokine profiles in patients with allergic rhinitis during allergen-specific immunotherapy with and without added vitamin D

“Picking the Harmony”: The Science Behind Immunotherapy Treatments

“Rhythm of Success”: Sustaining Benefits in Allergen Immunotherapy

“Tuning In”: Patient Profiles Orchestrating Optimized Response to Immunotherapy

Allergen immunotherapy in clinical studies

Allergen immunotherapy – Basic and clinical perspective

AllergoOncology: Application of the basophil activation test (BAT) in pre-clinical testing and the first-in-class clinical trial of anti-cancer IgE immunotherapy

AllergoOncology: The role of BAT in pre-clinical and clinical assessments of potential hypersensitivity to anti-cancer IgE immunotherapy

BDNF as a biomarker for evaluating clinical response in allergic rhinitis patients undergoing allergen-specific immunotherapy

Basophil activation test as a marker of desensitization in Very Low-Dose Multi-Nut Immunotherapy and Very Low-Dose Peanut Oral Immunotherapy

Clinical Assessment of Specific Immunotherapy Efficacy in Individuals with House Dust Mite-Induced Allergic Rhinoconjunctivitis

Clinical Characteristics of Anaphylaxis Secondary to Subcutaneous Allergen-Specific Immunotherapy in a Pediatric Hospital in Mexico

Clinical Evaluation of subcutaneous immunotherapy (SCIT) containing a mixture of mites, in depot polymerized formulation without dilutional effect. Results from a prospective multicenter study

Clinical and immunological aspects in allergen immunotherapy

Clinical and immunological comparison between two subcutaneous immunotherapy products in children with allergic rhinitis

Clinical evaluation of an immunotherapy treatment with Vespa velutina venom in allergic patients. Results from a prospective multicenter Study: W-STING Study

Clinical outcomes used in allergen immunotherapy in allergic asthma in the era of Data Science

Clinical remission of allergic rhinoconjunctivitis with a 300IR 5-grass pollen sublingual immunotherapy tablet

Clinical studies on Allergen Immunotherapy with inhaled allergens: optimization and standardization of methodological approaches

Clinical studies on allergen immunotherapy with inhaled allergens: optimization and standardization of methodological approaches

Coordinated specific IgG2 and IgE responses are associated with high clinical benefit of allergen immunotherapy with 300 IR house dust mite sublingual tablets in a large European cohort

Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: PATIENT’S RESULTS

Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: DOCTOR’S RESULTS

Effectiveness of allergy immunotherapy on asthma medication use and asthma exacerbations: Results from the Real world Evidence of aLlergy immunotherapY (RELY) study

Effectiveness of allergy immunotherapy on symptom-relieving medication use: Results from the Real world Evidence of aLlergy immunotherapY (RELY) study

Efficacy and safety of allergen immunotherapy in clinical practice

Evaluation of Patients with Venom Immunotherapy Indication When Immunotherapy Preparation Could Not Be Obtained

First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma

ILIT.NU: Intralymphatic immunotherapy and placebo affected cSMS similarly in grass pollen allergic individuals in a large clinical trial

Immunotherapy with Vespa velutina nigrithorax venom: safety of ultra-rush protocol and preliminary clinical results

Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units

Increase in maximum tolerated dose and decrease in symptom severity during food challenge in a clinical trial of oral immunotherapy for peanut allergy in children aged 1 to 3 years

Key challenges in endpoints of clinical trials in AIT- Clinical vs mechanistic parameters

Pediatric patients undergoing immunotherapy with alternaria alternata: demographic and clinical characterization

Predicting clinical response to allergen-specific immunotherapy to D. pteronyssinus using serological pre-treatment parameters

Safety Profile and Clinical Outcome of Sublingual Immunotherapy (SLIT) with Pru p 3 in Patients with LTP Allergy Undergoing Food Reintroduction

Safety of Hymenoptera Venom Immunotherapy in Patients with Oncological and Autoimmune Diseases: A Clinical Case Series

Safety profile in clinical trials of sublingual immunotherapy with carbamylated monomeric allergoid

Short-term benefits of sublingual immunotherapy in routine clinical practice: Patient Benefit Index by class in the observational, prospective, longitudinal study PRACTIS

Short-term benefits of sublingual immunotherapy in routine clinical practice: deciphering factors influencing the patient satisfaction in the observational, prospective, longitudinal study PRACTIS

Sympout study: Evolution of clinical parameters in a pediatric population allergic to pollens or house dust mites treated with sublingual immunotherapy in liquid formulation standardized in TBU/ml

TAPAS – a long-term non-interventional study evaluating MCT (MicroCrystalline Tyrosine)-associated allergoids shows non-inferiority of clinical effectiveness in children compared to adults during a 3-year course of allergen immunotherapy

The SQ HDM SLIT-tablet improves QoL and reduces clinical symptoms in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis – results from a global phase III clinical trial

The effect of the sphenopalatine ganglion acupuncture on the clinical efficacy of cluster immunotherapy in patients with allergic rhinitis

Updates in the clinical management of allergen immunotherapy

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website